Abstract:The periodic emergence of novel coronaviruses (CoVs) represents an ongoing public health concern with significant health and financial burden worldwide. The most recent occurrence originated in the city of Wuhan, China where a novel coronavirus (SARS-CoV-2) emerged causing severe respiratory illness and pneumonia. The continual emergence of novel coronaviruses underscores the importance of developing effective vaccines as well as novel therapeutic options that target either viral functions or host factors recr… Show more
“…Recently two crystal structure of SARS-CoV-2 NSP1 corresponding to residues 10–127 (PDB ID: 7K7P ) and 13–127 (PDB ID: 7K3N ) have been reported, which suggest that residue 1–10 and 130–180 are highly flexible and cannot be crystallized ( Fig. 1 ) ( Semper et al., 2021 ; Clark et al., 2021 ). Also, the cryo-EM structure of SARS-CoV-2 NSP1-CTR has been reported in the presence of a binding partner ( Thoms et al., 2020 ; Schubert et al., 2020 ).…”
The NSP1– C terminal structure in complex with ribosome using cryo-EM is available now, and the N-terminal region structure in isolation is also deciphered in literature. However, as a reductionist approach, the conformation of NSP1– C terminal region (NSP1-CTR; amino acids 131–180) has not been studied in isolation. We found that NSP1-CTR conformation is disordered in an aqueous solution. Further, we examined the conformational propensity towards alpha-helical structure using trifluoroethanol, we observed induction of helical structure conformation using CD spectroscopy. Additionally, in SDS, NSP1-CTR shows a conformational change from disordered to ordered, possibly gaining alpha-helix in part. But in the presence of neutral lipid DOPC, a slight change in conformation is observed, which implies the possible role of hydrophobic interaction and electrostatic interaction on the conformational changes of NSP1. Fluorescence-based studies have shown a blue shift and fluorescence quenching in the presence of SDS, TFE, and lipid vesicles. In agreement with these results, fluorescence lifetime and fluorescence anisotropy decay suggest a change in conformational dynamics. The zeta potential studies further validated that the conformational dynamics are primarily because of hydrophobic interaction. These experimental studies were complemented through Molecular Dynamics (MD) simulations, which have shown a good correlation and testifies our experiments. We believe that the intrinsically disordered nature of the NSP1-CTR will have implications for enhanced molecular recognition feature properties of this IDR, which may add disorder to order transition and disorder-based binding promiscuity with its interacting proteins.
“…Recently two crystal structure of SARS-CoV-2 NSP1 corresponding to residues 10–127 (PDB ID: 7K7P ) and 13–127 (PDB ID: 7K3N ) have been reported, which suggest that residue 1–10 and 130–180 are highly flexible and cannot be crystallized ( Fig. 1 ) ( Semper et al., 2021 ; Clark et al., 2021 ). Also, the cryo-EM structure of SARS-CoV-2 NSP1-CTR has been reported in the presence of a binding partner ( Thoms et al., 2020 ; Schubert et al., 2020 ).…”
The NSP1– C terminal structure in complex with ribosome using cryo-EM is available now, and the N-terminal region structure in isolation is also deciphered in literature. However, as a reductionist approach, the conformation of NSP1– C terminal region (NSP1-CTR; amino acids 131–180) has not been studied in isolation. We found that NSP1-CTR conformation is disordered in an aqueous solution. Further, we examined the conformational propensity towards alpha-helical structure using trifluoroethanol, we observed induction of helical structure conformation using CD spectroscopy. Additionally, in SDS, NSP1-CTR shows a conformational change from disordered to ordered, possibly gaining alpha-helix in part. But in the presence of neutral lipid DOPC, a slight change in conformation is observed, which implies the possible role of hydrophobic interaction and electrostatic interaction on the conformational changes of NSP1. Fluorescence-based studies have shown a blue shift and fluorescence quenching in the presence of SDS, TFE, and lipid vesicles. In agreement with these results, fluorescence lifetime and fluorescence anisotropy decay suggest a change in conformational dynamics. The zeta potential studies further validated that the conformational dynamics are primarily because of hydrophobic interaction. These experimental studies were complemented through Molecular Dynamics (MD) simulations, which have shown a good correlation and testifies our experiments. We believe that the intrinsically disordered nature of the NSP1-CTR will have implications for enhanced molecular recognition feature properties of this IDR, which may add disorder to order transition and disorder-based binding promiscuity with its interacting proteins.
“…We next sought to better define which residues within the N-terminal domain are required for suppressing gene expression. Guided by existing structural data for the N-terminus 27,28 , we mutated a series of conserved, surface exposed and charged residues (E36A/E37A, E55A/E57A/K58A, R99A and R119A/K120A) (Figure S3A). The mutants were then screened using our GFP reporter assay alongside the R124A/K125A and K164A/H165A controls to determine the effects on protein translation and mRNA decay.…”
Section: Resultsmentioning
confidence: 99%
“…Further, the identification of a double point mutant at the border of the N-terminal and central domains of SARS CoV nsp1 that disrupts mRNA cleavage but retains translational repression activity has led to the hypothesis that mRNA cleavage occurs subsequent to translational repression and is a functionally separable phenotype 21 . The structure of the N-terminal domain in isolation has been solved, but neither it nor the unstructured central region was resolved in the cryo-electron microscopy structures of CoV-2 nsp1 bound to the 40S ribosomal subunit and thus their role in host shutoff is unclear 28,29 .…”
Nonstructural protein 1 (nsp1) is the first viral protein synthesized during coronavirus (CoV) infection and is a key virulence factor that dampens the innate immune response. It restricts cellular gene expression through a combination of inhibiting translation by blocking the mRNA entry channel of the 40S ribosomal subunit and by promoting mRNA degradation. We performed a detailed structure-guided mutational analysis of CoV-2 nsp1 coupled with in vitro and cell-based functional assays, revealing insight into how it coordinates these activities against host but not viral mRNA. We found that residues in the N-terminal and central regions of nsp1 not involved in docking into the 40S mRNA entry channel nonetheless stabilize its association with the ribosome and mRNA, thereby enhancing its restriction of host gene expression. These residues are also critical for the ability of mRNA containing the CoV-2 leader sequence to escape translational repression. Notably, we identify CoV-2 nsp1 mutants that gain the ability to repress translation of viral leader-containing transcripts. These data support a model in which viral mRNA binding functionally alters the association of nsp1 with the ribosome, which has implications for drug targeting and understanding how engineered or emerging mutations in CoV-2 nsp1 could attenuate the virus.
“…Among them, β -CoV has become the utmost concern of the world due to its ability to cause serious illness in the human population, like the Middle East respiratory syndrome–related coronavirus (MERS-CoV), SARS-CoV, and SARS-CoV-2, which cause fatal respiratory tract infection in humans ( Lu et al, 2020 ). The structural and nonstructural information of SARS-CoV-2 has already been explained and explored by many studies available in the literature ( Hillen et al, 2020 ; Jin et al, 2020 ; Clark et al, 2021 ; Hasana et al, 2021 ; Semper et al, 2021 ).…”
COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has a disastrous effect on mankind due to the contagious and rapid nature of its spread. Although vaccines for SARS-CoV-2 have been successfully developed, the proven, effective, and specific therapeutic molecules are yet to be identified for the treatment. The repurposing of existing drugs and recognition of new medicines are continuously in progress. Efforts are being made to single out plant-based novel therapeutic compounds. As a result, some of these biomolecules are in their testing phase. During these efforts, the whole-genome sequencing of SARS-CoV-2 has given the direction to explore the omics systems and approaches to overcome this unprecedented health challenge globally. Genome, proteome, and metagenome sequence analyses have helped identify virus nature, thereby assisting in understanding the molecular mechanism, structural understanding, and disease propagation. The multi-omics approaches offer various tools and strategies for identifying potential therapeutic biomolecules for COVID-19 and exploring the plants producing biomolecules that can be used as biopharmaceutical products. This review explores the available multi-omics approaches and their scope to investigate the therapeutic promises of plant-based biomolecules in treating SARS-CoV-2 infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.